Such side effects may help explain why 65 percent of people without type 2 diabetes who take a GLP-1 drug quit within a year, scientists suggested in January in JAMA Network Open. Less than four emergency department visits occur for every 1,000 patients dispensed semaglutide, researchers estimated in April in the Annals of Internal Medicine. […]
